(19)
(11) EP 3 784 265 A2

(12)

(88) Date of publication A3:
02.01.2020

(43) Date of publication:
03.03.2021 Bulletin 2021/09

(21) Application number: 19791705.7

(22) Date of filing: 17.04.2019
(51) International Patent Classification (IPC): 
A61K 38/17(2006.01)
A61P 3/10(2006.01)
A61P 1/16(2006.01)
C07K 14/47(2006.01)
(86) International application number:
PCT/IB2019/053194
(87) International publication number:
WO 2019/207427 (31.10.2019 Gazette 2019/44)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 25.04.2018 US 201862662492 P

(71) Applicant: Janssen Pharmaceutica NV
2340 Beerse (BE)

(72) Inventors:
  • JIAN, Wenying
    Spring House, PA 19477 (US)
  • PATCH, Raymond
    Spring House, PA 19477 (US)
  • ZHANG, Rui
    Spring House, PA 19477 (US)
  • ZHENG, Songmao
    Spring House, PA 19477 (US)
  • HINKE, Simon
    Spring House, PA 19477 (US)

(74) Representative: Warner, James Alexander 
Carpmaels & Ransford LLP One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) THIOETHER CYCLIC PEPTIDE AMYLIN RECEPTOR MODULATORS